BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10619721)

  • 21. Coexistence of Parkinson's disease and myasthenia gravis: a case report.
    Kao KP; Kwan SY; Lin KP; Chang YC
    Clin Neurol Neurosurg; 1993 Jun; 95(2):137-9. PubMed ID: 8344012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
    Takahashi K; Inoue Y; Matsuda O; Takemura T; Yoshimura A
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):394-8. PubMed ID: 10998921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of paraneoplastic myasthenia-like syndrome: electrophysiological and clinical peculiarities].
    Cosi V; Faggi L; Piccolo G
    Riv Neurol; 1977; 47(2):148-56. PubMed ID: 141096
    [No Abstract]   [Full Text] [Related]  

  • 24. Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies.
    Lo HP; Bertini E; Mirabella M; Domazetovska A; Dale RC; Petrini S; D'Amico A; Valente EM; Barresi R; Roberts M; Tozzi G; Tasca G; Cooper ST; Straub V; North KN
    Neuromuscul Disord; 2011 Mar; 21(3):194-203. PubMed ID: 21295981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma.
    Gajra A; Vajpayee N; Grethlein SJ
    Am J Hematol; 2004 Oct; 77(2):196-7. PubMed ID: 15389902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
    Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW
    J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence.
    Gilhus NE; Hong Y
    Eur J Neurol; 2018 Dec; 25(12):1402-1409. PubMed ID: 30133097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of myasthenia gravis and Behçet's disease: A case report.
    Kisabay A; Sari US; Boyaci R; Batum M; Yilmaz H; Selcuki D
    Neurol Neurochir Pol; 2016; 50(4):284-7. PubMed ID: 27375145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenia Gravis and Its Aeromedical Implications.
    Jagathesan T; O'Brien MD
    Aerosp Med Hum Perform; 2017 Jan; 88(1):30-33. PubMed ID: 28061919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
    Bau V; Hanisch F; Hain B; Zierz S
    Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment.
    Gilhus NE; Andersen H; Andersen LK; Boldingh M; Laakso S; Leopoldsdottir MO; Madsen S; Piehl F; Popperud TH; Punga AR; Schirakow L; Vissing J
    Eur J Neurol; 2024 May; 31(5):e16229. PubMed ID: 38321574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
    Cosi V; Lombardi M; Erbetta A; Piccolo G
    Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of patients with Myasthenia gravis from the Henan province, China.
    Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
    Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired rippling muscle disease associated with mild myasthenia gravis: a case report.
    van Schaik SM; Kwa VI; van der Kooi AJ
    J Neurol; 2009 Jul; 256(7):1187-8. PubMed ID: 19277764
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of myasthenia--I.
    Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
    Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
    Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
    [No Abstract]   [Full Text] [Related]  

  • 38. Myasthenia gravis associated with lupus nephritis.
    Lee H; Chen W; Su K; Chou C; Tsai C
    Lupus; 2008 Sep; 17(9):860-1. PubMed ID: 18755870
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1976 Dec; 96(34-36):1803-5. PubMed ID: 189451
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: a case report].
    Kurokawa T; Nishiyama T; Yamamoto R; Kishida H; Hakii Y; Kuroiwa Y
    Rinsho Shinkeigaku; 2008 Sep; 48(9):666-9. PubMed ID: 19048951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.